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Background: Natriuretic peptides (NPs) are peptide hormones that exert their biological actions by binding to
three types of cell surface natriuretic peptide receptors (NPRs). The receptor NPR-B binding C-type natriuretic
peptide (CNP) acts locally as a paracrine and/or autocrine regulator in a wide variety of tissues. Mutations in the
gene NPR2 have been shown to cause acromesomelic dysplasia-type Maroteaux (AMDM), an autosomal recessive
skeletal disproportionate dwarfism disorder in humans.
Methods: In the study, presented here, genotyping of six consanguineous families of Pakistani origin with AMDM
was carried out using polymorphic microsatellite markers, which are closely linked to the gene NPR2 on
chromosome 9p21-p12. To screen for mutations in the gene NPR2, all of its coding exons and splice junction sites
were PCR amplified from genomic DNA of affected and unaffected individuals of the families and sequenced.
Results: Sequence analysis of the gene NPR2 identified a novel missence mutation (p.T907M) in five families, and a
splice donor site mutation c.2986 + 2 T>G in the other family.
Conclusion: We have described two novel mutations in the gene NPR2. The presence of the same mutation (p.
T907M) and haplotype in five families (A, B, C, D, E) is suggestive of a founder effect.
Keywords: Acromesomelic dysplasia-type Maroteaux, gene NPR2, missence mutation (T907M), splice site mutation
c.2986 + 2 T>GBackground
Acromesomelic Dysplasia, type Maroteaux (AMDM) is
characterized by disproportionate shortening of skeletal
elements, predominantly affecting the middle segments
(forearms and forelegs) and distal segments (hands and
feet) of appendicular skeleton. In addition, axial skeletal
involvement occurs characterized by wedging of verte-
bral bodies, with dorsal margins being shorter than the
ventral margins. Mode of inheritance of AMDM (MIM
602875) is an autosomal recessive with a prevalence of
1/1,000,000 [1]. Skeletal growth in AMDM patients falls
off sharply after birth causing abnormal growth plate
and short misshapen bones in the extremities and spine* Correspondence: wahmadqau@gmail.com
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reproduction in any medium, provided the or[2]. Carrier parents of AMDM children are shorter than
average [2].
Acromesomelic dysplasia was mapped on chromosome
9p13-q12 [3]. Later, Bartels et al. [4] identified mutations
in gene NPR2, encoding natriuretic peptide receptor B
(NPR-B), underlying Acromesomelic Dysplasia, Type Mar-
oteaux. Natriuretic peptides (NPs) comprise a family of
hormones involved in the regulation of various physio-
logical processes including cardiac growth, blood pressure,
axonal path finding and endochondral ossification by
binding to cell surface receptors called natriuretic peptide
receptors (NPRs) [5-7]. Three different subtypes (A, B, C)
of NPRs have been identified [8]. The NPR-B is expressed
in various tissues and cell populations like heart, vessels,
brain, uterus and chondrocytes [8-10]. NPR-B is a receptor
for C-type natriuretic peptide (CNP) that acts locally as a
paracrine and/or autocrine regulator in a wide variety of. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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binding domain, a single hydrophobic transmembrane re-
gion, an intracellular kinase homology domain (KHD),
and carboxyl- terminal guanylyl cyclase (GC) domain
[11,12]. The NPR-A and NPR-B mediate their biological
function through GC domains.
In the report, presented here, we have investigated 6
consanguineous Pakistani families with multiple affected
individuals showing typical features of acromesomelic dys-
plasia, Type Maroteaux. DNA sequence analysis of the
gene NPR2 detected a novel homozygous missense muta-
tion (Thr907Met) in five families (A-E) and a novel splice
site mutation c.2986+ 2 T>G [IVS20+ 2 T>G] in
affected individuals of the sixth family (F).
Methods
Subjects and ethical approval of the study
The present study presents six consanguineous families (A,
B, C, D, E, F) of Pakistani origin exhibiting autosomal reces-
sive form of acromesomelic dysplasia, type Maroteaux
(AMDM). Five families (A, B, C, D, E) were ascertained
from Punjab province and family F from Sindh province of
Pakistan. Forty four individuals including 18 affected volun-
teered to participate in the study (Figure 1). The study was
conducted after obtaining informed consent from theFigure 1 Pedigrees of six consanguineous Pakistani families segregat
of consanguineous union. Clear symbols represent unaffected individuals w
through a symbol is indicative of a deceased family member. Symbols with
whom DNA samples were available for molecular analysis.patients and their parents, and permission to undertake the
study was obtained from the institutional review board
(IRB) of Quaid-i-Azam University, Islamabad Pakistan.
DNA isolation and genotyping
Blood samples from both affected and unaffected indivi-
duals of the six families were collected in EDTA contain-
ing vacutainer sets (BD, Franklin NG, USA). Genomic
DNA from the blood samples was extracted using GenE-
luteTM Blood Genomic DNA Kit (Sigma-Aldrich, MO,
USA). To quantify DNA, Nanodrop-1000 spectrophotom-
eter (Thermal Scientific, Wilmington, USA) was used,
measuring optical density at 260 nm and diluted to 40–
50 ng/μl for amplification by polymerase chain reaction
(PCR). PCR amplifications conditions for microsatellite
markers were the same as described earlier by Khan et al.
[13]. Allele size for respective microsatellite markers were
determined using 05-bp, 10-bp and 20-bp DNA ladders
(MBI, FermentasW, York, UK).
Previously, it has been reported that mutations in the
gene NPR2 result in acromesomelic dysplasia, type Mar-
oteaux (AMDM). Therefore, linkage in the six families
was tested by genotyping microsatellite markers
(D9S1118, D9S1845, D9S1817, D9S50, D9S1874) linked
to the gene NPR2 mapped on chromosome 9p13-q12.ing autosomal recessive form of AMDM. Double lines are indicative
hile filled symbols represent affected individuals. The diagonal line
asterisks indicate individuals who were clinically examined and for
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All 22 exons of NPR2 with adjacent sequences of exon-
intron borders were amplified by PCR using gene specific
primers. The amplification conditions used were 950 C for
1 minute, followed by 30 cycles of 950 C for 35 seconds,
600 C for 35 seconds, and 700 C for 3.5 minutes, followed
by a single incubation at 700 C for 10 minutes. The PCR
products were purified using the Rapid PCR Purification
System 9700 (Marligen Biosciences, Ijamsville, MD, USA)
and sequenced bidirectionally (both forward and reverse)
following dideoxy chain termination method using DTCS
Quick Start sequencing kit on CEQ8800 DNA sequencer
(Beckman Coulter, Inc. Brea, CA USA) according to the
manufacturer's instructions. Sequence variants were identi-
fied via BioEdit sequence alignment editor version 6.0.7
(http://www.mbio.ncsu.edu/BioEdit/bioedit.html). PCR pri-
mers were designed using the ‘Primer3’ program (http://
frodo.wi.mit.edu/primer3) [14] and checked for specificity
using basic local alignment search tool (BLAST; http://
www.ncbi.nlm.nih.gov/blast). The possible impact of amino
acid substitution on the structure of the NPR-B protein was
examined with PolyPhen2 tools (http://genetics.bwh.har-
vard.edu/pph2). Evolutionary conservation of the mutated




Affected individuals in all six families exhibited features
of Acromesomelic Dysplasia, Type Maroteaux (AMDM).Table 1 Comparison of heights of individuals affected with A
population
Family Affected Member Sex Age (Years) Height (cm)
A V-I M 27 118
A V-4 M 38 128
A V-6 M 24 105
A V-7 F 17 101
B V-2 M 11 89
C V-4 F 22 103
C VI-2 M 18 104
D V-3 M 36 127
D VI-3 M 26 113
D VI-6 M 9 73
E V-2 F 20 102
E V-3 F 17 96
E V-4 F 14 91
E V-5 F 12 82
F IV-3 F 24 109
F IV-5 M 21 113
NA, not available.Ages of the affected members ranged from 9–38 years at
the time of the study. Table 1 lists heights of the affected
individuals of the families. Mostly similar clinical fea-
tures were observed in affected members of all the six
families (Table 2, Figure 2a-e). However, affected indivi-
duals in family F had long faces (Figure 2h). Fingers of
the affected members were extremely short with redun-
dant skin. Limbs showed marked shortening in the mid-
dle and distal segments. A skeletal survey revealed
disproportionate mesomelic shortening of the arms, pha-
langes and metacarpal bones. Sterility was not observed
in patients of all the six families, presented here.
Radiographs of affected individuals (V-4 of family A,
V-3 of family D, IV-5 of family F) showed bilateral
triangular distal epiphysis of the radius and relative
shortening of the ulna. Metacarpels were short and
stubby bilaterally. Mild reduction in the heights of verte-
bral bodies was noted in the thoracic and lumbar spine
(mild platyspondyly).
Linkage and mutation analysis
Genotyping data and haplotype analysis showed link-
age of all the six families to the gene NPR2 mapped
on chromosome 9p13-q12. Subsequently, the gene
NPR2 was sequenced in two affected and one un-
affected individual of each of the six families. Upon
identifying the sequence variants, the same exon of
the gene was sequenced in rest of the affected and
unaffected individuals of the respective family. Se-
quence analysis of the gene NPR2 was performedMDM, heterozygous parents and control Pakistani
Father Height (cm) Mother Height (cm)
(Average Matched Control Height of Pakistani Population)
158.5 (164.0) NA (152.5)
NA (164.0) 147.0 (152.5)
155.0 (164.0) 145.5 (152.5)
155.0 (164.0) 145.5 (152.5)
158.0 (164.0) 146.0 (152.5)
NA (164.0) NA (152.5)
NA (164.0) 145.0 (152.5)
NA (164.0) NA (152.5)
153.0 (164.0) 147.0 (152.5)
157.0 (164.0) 146.5 (152.5)
NA (164.0) 144.5 (152.5)
NA (164.0) 144.5 (152.5)
NA (164.0) 144.5 (152.5)
NA (164.0) 144.5 (152.5)
NA (164.0) 147.5 (152.5)
NA (164.0) 147.5 (152.5)
Table 2 Skeletal malformations observed in families with AMDM
Family Organs Clinical Features Radiological Features
A Long bones Short middle and distal segments Ulna shorter than radius, bilateral
triangular distal epiphysis and bowing of the
radius
Hands and feet Short and broad fingers with redundant skin Short and broad phalanges. Short and
stubby metacarpal and metatarsal bones.
Vertebral abnormalities Mild reduction in the heights of the
vertebral bodies in the thoracic and lumbar
spine (Mild platyspondyly)
B Long bones Short middle and distal segments Ulna shorter than radius, bowing of the radius
Hands and feet Extremely short and broad fingers with
redundant skin
Short and broad phalanges, metacarpal and
metatarsal bones
Vertebral abnormalities Not available
C Long bones Short and misshaped middle and distal segments Not available
Hands and feet Extremely short and broad fingers with redundant
skin, great toe relatively large
Not available
Vertebral abnormalities Not available
D Long bones Short middle and distal segments Ulna shorter than radius, bilateral triangular
distal epiphysis and bowing of the radius
Hands and feet Short and broad fingers with redundant skin Short and broad phalanges, metacarpal and
metatarsal bones
Vertebral abnormalities Reduction in the heights in the thoracic
and lumbar spine (Mild platyspondyly)
E Long bones Short and misshaped middle and distal segments Not available
Hands and feet Short and broad fingers with slight redundant skin Not available
Vertebral abnormalities Not available
F Long bones Short and misshaped middle and distal segments Ulna shorter than radius, bilateral triangular
distal appearance of epiphysis and bowing of
the radius
Hands and feet Short and broad fingers with redundant skin,
great toe relatively large
Short and broad phalanges, metacarpal and
metatarsal bones
Vertebral abnormalities Mild reduction in the heights of the vertebral
bodies in the thoracic and lumbar spine
(Mild platyspondyly)
Face Long face
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Sequence analysis of the gene NPR2 detected a homo-
zygous C to T transition at nucleotide position 2720
(c.2720 C>T) in affected individuals of the five families
(A, B, C, D, E) (Figure 3a, b, c). This sequence change
resulted in substitution of a threonine residue with me-
thionine at amino acid position 907 (p.T907M) in the
NPR-B protein (Figure 4). Upon examining the haplo-
types, it was observed that a missense mutation
(c.2720 C>T; p.T907M) in the families A-E appeared
on very similar haplotypes, suggesting that the mutation
in these five families was due to single mutation event
(Figure 3d).
In family F, sequence analysis detected a splice donor
site mutation in intron 20 of the gene (c.2986 + 2 T>G)
(Figure 3e, f, g). The sequence variants detected in
affected members were present in heterozygous state in
obligate carriers of the families. To exclude thepossibility that the splice site mutation identified in the
family F does not represents a neutral polymorphism in
the Pakistani population, a panel of 100 ethnically
matched, unrelated unaffected control individuals were
screened directly by sequencing. Non-polymorphic na-
ture of the missense mutation identified in five families
was verified by screening 250 unrelated, unaffected con-
trol individuals.
Discussion
Six consanguineous Pakistani families (A-F), exhibit-
ing typical features of Acromesomelic Dysplasia, type
Maroteaux (AMDM), were investigated in the present
study. Five of these families (A-E) were probably dis-
tantly related. Diagnosis of AMDM in the six families
was based upon characteristic physical and x-ray find-
ings in the affected individuals. Physical and clinical
features observed in affected members of the six fam-
ilies were similar to those reported earlier in several
Figure 2 Clinical features of AMDM. Bowing of forearm in an affected member (V-8) in family A (a), affected members including V-5 in family
B, V-4 in family C, VI-6 in family D, V-2 in family E showing short fingers and redundant skin (b-e), an affected member V-4 at 38 years of age with
his younger brother V-5 at 27 years of age in family A (f), an affected member V-3 at 36 years of age with a carrier VI-1 at 29 years of age in
family D along with one of the authors (g), an affected member IV-5 in family F showing short stature and short extremities (h). Radiograph of
hand and forearm of an affected member V-4 in family A (i), V-3 in family D (j), IV-5 of family F (k), showing epiphysis of the radius, shortening of
ulna, short and stubby metacarpels. Radiograph of vertebral column of an affected member IV-5 in family F showing mild platyspondyly (l).
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[3,4,15,16]. Affected individuals of family F had long
faces, a feature not observed in five other families,
presented here. An affected individual with a long
face was also reported by Hachiya et al. [16] in a
Japanese patient. The heterozygous carriers in all the
present six families were shorter in statures. Findings
of the reduced statures of the heterozygous carriers
were reported earlier in other families with AMDM
[4,15]. Tamura et al. [6] observed reduced stature in
mouse heterozygous for the NPR-B mutation. The
shorter stature found in heterozygous carriers isprobably caused by a dominant-negative effect of the
mutant allele as suggested by Hachiya et al. [16].
Genotyping analysis in the six families established link-
age to the gene NPR2, mapped earlier on chromosome
9p13-q12 [3,4]. DNA sequence analysis of the gene in
six families (A-F) identified two novel disease causing se-
quence variants. In five families (A-E), a novel homozy-
gous missense mutation (c.2720 C>T; p.T907M) was
detected in all sixteen affected individuals. In family F,
sequence analysis identified a novel splice donor site
mutation in intron 20 of the gene (c.2986 + 2 T>G). To
date, 23 mutations in the gene NPR2 have been reported
Figure 3 Sequence analysis of the two novel mutations including c.2027 C> T (p.Thr907Met) identified in the gene NPR2 in the five
families (A-E), and c.2986+ 2 T>G [IVS20+ 2 T>G] in family F. The upper panels (a, e) represent the nucleotide sequences in the
unaffected individuals, the middle panels (b, f) in the heterozygous carriers and the lower panels (c, g) in the affected individuals. Panel d shows
shared haplotypes of the gene NPR2 linked microsatellite markers in affected individuals in five families (A-E). Disease-interval is flanked by
markers D9S1118 and D9S1874. Arrows in the panels indicate position of the nucleotide change.
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around the world [4,15,16]. This included 4 nonsense, 5
frameshift, 2 splice site and 12 missense mutations in 23
families with AMDM reported.
The human NPR2 gene spans about 16.5 kb, contains
22 exons encoding 1047 amino acids protein [3]. PotterFigure 4 a. Schematic representation of the human NPR-B structural
T907Met) identified in NPR-B in the five families (A-E) is indicated by
Homology; GC, Guanylyl Cyclase; aa, amino acid. b. Partial amino acid sequ
arrow indicates threonine (T) residue conserved across different species.[17] has shown that guanylyl cyclase-linked natriuretic
peptide receptors consist of 450 amino acids extracellu-
lar ligand-binding domain, 20 amino acids of single
hydrophobic transmembrane domain and 570 amino
acids of intracellular domain. Intracellular domain con-
tains 3 subdomains including a kinase homology domainand functional domains. Position of the missense mutation (p.
an arrow. LB, Ligand Binding: TM, Trans Membrane; KH, Kinase
ence comparison of human NPR-B protein with other orthologs. An
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main of 40 amino acids, and carboxyl-terminal guanylyl
cyclase catalytic domain of 250 amino acids [18].
A homozygous missense mutation (p.T907M), identi-
fied in five families, in the present study, is lying in the
guanylyl cyclase domain of the NPR-B. The threonine
residue at position 907 is highly conserved among vari-
ous species. Analysis of the protein sequence by protein
prediction tool PolyPhen (http://genetics.bwh.harvard.
edu/pph/) revealed that the substitution of polar threo-
nine by a non-polar amino acid methionine (p.T907M)
could potentially have a damaging effect on NPR2 struc-
ture with a PSIC (Position specific independent counts)
score of 1.00. Hume et al. [19] hypothesized that mis-
sense mutations in NPR-B, resulting in AMDM, is pri-
marily due to arrest of the receptor trafficking in the
endoplasmic reticulum (ER). Therefore, it is more likely
that the missense mutation (p.T907M), identified here,
also results in retention of the mutant NPR-B in the ER
and has become non-functional.
The splice site mutation (c.2986 + 2 T>G), identified
in one family here, can cause skipping of exon 20, as
well as abolish most of the c-terminal guanylyl cyclase
domain of NPR2 protein. This leads to synthesis of trun-
cated or non-functional protein, possibly due to
nonsense-mediated mRNA decay (NMRD) [20].
At least two studies have shown that mutations in
GC-binding domain in the gene Npr2 result in
impaired endochondral ossification and severe dwarf-
ism in mice [6,21]. Since NPR-B mediate its biological
function through GC domain, it is highly likely that
the effect on the structure of NPR-B will affect the
natriuretic peptide-dependent physiological response
occurs through synthesis of cGMP. This in turns will
affect the cGMP signaling effects which occurs
through cGMP binding proteins including cGMP
dependent protein kinase (PKG), cGMP binding phos-
phodiesterases (PDEs) and cyclic nucleotide-gated ion
channels. The best studied cGMP signaling effects
occurs through PKGs. Deletion of a membrane bound
PKGII, which has been found in high concentration
in brain, chondrocytes and bones [22], results in
dwarfism in rodents [22,23]. The genetic data pertain-
ing to mutations identified in Nppc and Npr-b in
mice and NPR-B in human clearly showed the in-
volvement of CNP/NPR-B/cGMP signaling pathway in
bone development.
Conclusions
We have reported two novel mutations in the gene
NPR2, which result in Acromesomelic Dysplasia, type
Maroteaux (AMDM). The presence of the same muta-
tion (p.T907M) and haplotype in five families (A, B, C,
D, E) is suggestive of a founder effect. The study,presented here, confirm the significant role assigned to
NPR2 in development of bones in human.
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